12 research outputs found
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
Background: Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world. In Egypt, HCC was reported to account for
about 4.7% of chronic liver disease (CLD) patients. Squamous cell
carcinoma antigen (SCCA) has been reported to be strongly expressed in
HCC tissue hampering its extensive use in clinical practice. Aim: To
evaluate the clinical usefulness of serum SCCA levels as a serological
marker for early detection of HCC among high-risk patients compared to
AFP. Materials and Methods: The study comprised of three groups.
Group A included 30 patients with CLD diagnosed based on clinical,
laboratory, and ultrasonographical investigations; group B included 49
patients with HCC diagnostically confirmed by spiral CT, elevated
alfafetoprotein (AFP), and/or liver biopsy; and group C, the control
group, included 15 healthy subjects matched for age and sex. All groups
were subjected to thorough history taking, full clinical examination,
and laboratory investigations including liver functions, viral markers,
and AFP and SCCA estimation using ELISA technique. Results: This study
revealed a highly significant difference between patients with HCC,
CLD, and controls regarding serum SCCA levels (5.138 ± 7.689,
1.133 ± 0.516, and 0.787 ± 0.432 ng/ml, respectively). SCCA
level was persistently elevated in patients with HCC with normal AFP
levels representing its useful role in early detection and follow-up of
patients treated for HCC. The area under the curve (AUC) of SCCA was
0.869 (95% CI 0.783-0.929), the cut-off value was established at 1.5
ng/ml with sensitivity of 77.6% and specificity of 84.4%). The
difference between AUC of SCCA and that of AFP was 0.09 which mounted
statistical significance. Conclusions: SCCA could represent a useful
tool as a marker for detection of HCC
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
Background: Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world. In Egypt, HCC was reported to account for
about 4.7% of chronic liver disease (CLD) patients. Squamous cell
carcinoma antigen (SCCA) has been reported to be strongly expressed in
HCC tissue hampering its extensive use in clinical practice. Aim: To
evaluate the clinical usefulness of serum SCCA levels as a serological
marker for early detection of HCC among high-risk patients compared to
AFP. Materials and Methods: The study comprised of three groups.
Group A included 30 patients with CLD diagnosed based on clinical,
laboratory, and ultrasonographical investigations; group B included 49
patients with HCC diagnostically confirmed by spiral CT, elevated
alfafetoprotein (AFP), and/or liver biopsy; and group C, the control
group, included 15 healthy subjects matched for age and sex. All groups
were subjected to thorough history taking, full clinical examination,
and laboratory investigations including liver functions, viral markers,
and AFP and SCCA estimation using ELISA technique. Results: This study
revealed a highly significant difference between patients with HCC,
CLD, and controls regarding serum SCCA levels (5.138 \ub1 7.689,
1.133 \ub1 0.516, and 0.787 \ub1 0.432 ng/ml, respectively). SCCA
level was persistently elevated in patients with HCC with normal AFP
levels representing its useful role in early detection and follow-up of
patients treated for HCC. The area under the curve (AUC) of SCCA was
0.869 (95% CI 0.783-0.929), the cut-off value was established at 1.5
ng/ml with sensitivity of 77.6% and specificity of 84.4%). The
difference between AUC of SCCA and that of AFP was 0.09 which mounted
statistical significance. Conclusions: SCCA could represent a useful
tool as a marker for detection of HCC
Plasma lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with acute ischemic stroke
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
Background: Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world. In Egypt, HCC was reported to account for
about 4.7% of chronic liver disease (CLD) patients. Squamous cell
carcinoma antigen (SCCA) has been reported to be strongly expressed in
HCC tissue hampering its extensive use in clinical practice. Aim: To
evaluate the clinical usefulness of serum SCCA levels as a serological
marker for early detection of HCC among high-risk patients compared to
AFP. Materials and Methods: The study comprised of three groups.
Group A included 30 patients with CLD diagnosed based on clinical,
laboratory, and ultrasonographical investigations; group B included 49
patients with HCC diagnostically confirmed by spiral CT, elevated
alfafetoprotein (AFP), and/or liver biopsy; and group C, the control
group, included 15 healthy subjects matched for age and sex. All groups
were subjected to thorough history taking, full clinical examination,
and laboratory investigations including liver functions, viral markers,
and AFP and SCCA estimation using ELISA technique. Results: This study
revealed a highly significant difference between patients with HCC,
CLD, and controls regarding serum SCCA levels (5.138 ± 7.689,
1.133 ± 0.516, and 0.787 ± 0.432 ng/ml, respectively). SCCA
level was persistently elevated in patients with HCC with normal AFP
levels representing its useful role in early detection and follow-up of
patients treated for HCC. The area under the curve (AUC) of SCCA was
0.869 (95% CI 0.783-0.929), the cut-off value was established at 1.5
ng/ml with sensitivity of 77.6% and specificity of 84.4%). The
difference between AUC of SCCA and that of AFP was 0.09 which mounted
statistical significance. Conclusions: SCCA could represent a useful
tool as a marker for detection of HCC
Dietary supplementation of quebracho and chestnut tannins mix in rabbit: effects on live performances, digestibility, carcase traits, antioxidant status, faecal microbial load and economic value
Predictive ranking: a novel page ranking approach by estimating the web structure
Conference paperPageRank (PR) is one of the most popular ways to rank web pages. However, as the Web continues to grow in volume, it is becoming more and more difficult to crawl all the available pages. As a result, the page ranks computed by PR are only based on a subset of the whole Web. This produces inaccurate outcome because of the inherent incomplete information (dangling pages) that exist in the calculation. To overcome this incompleteness, we propose a new variant of the PageRank algorithm called, Predictive Ranking (PreR), in which different classes of dangling pages are analyzed individually so that the link structure can be predicted more accurately. We detail our proposed steps. Furthermore, experimental results show that this algorithm achieves encouraging results when compared with previous methods.Re-search Grants Councils of the HKSAR, China (CUHK4205/04E and CUHK4351/02E
Residues of imidacloprid insecticide and its efficacy on whitefly, Bemisia tabaci (gennadius) in tomato plants
Elevated lipid peroxides induced angiogenesis in proliferative diabetic retinopathy
Oxidative stress is associated with causation of diabetic vascular complications. A case–control study was undertaken to evaluate the association of platelet thiobarbituric acid reacting substances (TBARS) with the severity of diabetic retinopathy for the first time. Platelet TBARS levels were estimated using standard protocol. Platelet TBARS levels in the cases with non-proliferative diabetic retinopathy, proliferative diabetic retinopathy, and healthy controls were 0.56 ± 0.09, 0.69 ± 0.11 and 0.41 ± 0.1 nmol/h/108 platelets, respectively. A significant increase in platelet TBARS levels was observed in the cases as compared to controls (p < 0.001). Elevated TBARS levels were observed to significantly increase further during the proliferative stage of the disease (p < 0.01). The increase in platelet TBARS levels, and thereby at retinal level, is associated with angiogenesis in diabetic retinopathy. Supplemental anti-oxidant therapy in diabetic retinopathy may prevent ocular angiogenesis resulting as a consequence of oxidative stress